Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/25/2022
State Council Issues Notice on Major Tasks for Deepening Healthcare Re...
5/24/2022
Vir and WuXi Bio Terminate COVID Antibody Agreement
5/24/2022
ImaginAb and Yantai DongCheng Enter License Deal to Commercialize CD8...
5/24/2022
CASI and Tianshi Enter Sublicense Deal for Anti-Cd38 mAb CID-103 in Au...
5/23/2022
Fujifilm Completes Construction of Bioprocessing Innovation & Collabor...
5/23/2022
Novartis's Promacta Approved in China for Expanded Use in Children Ag...
5/23/2022
Sinohealth: Chinese Hospital Drug Sales Fell 4% in Q1/2022
5/23/2022
IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021
5/23/2022
VerImmune and Fosun Pharma Enter Licensing Deal for Virus-inspired Pa...
5/23/2022
Biopharma in China: The Emerging Global Force of Domestic Suppliers
5/20/2022
U.S., European Firms Rethink China Investment After Lockdowns
5/20/2022
VerImmune and Fosun in Deal for VerImmune's ViP Platform as Novel Im...
5/20/2022
Recent Executive Moves
5/19/2022
China Approves Bayer/MSD's Verquvo (vericiguat) for Chronic Heart Fail...
5/19/2022
CTTQ and Symphogen Enter Pact for Global Rights of Latter's mAb Sym022
5/19/2022
APAC Hospital Priorities 2022: Strategic Implications for Pharma Compa...
5/19/2022
Pediatric Drug Development A New Investment Area in China (PharmaDJ's ...
5/17/2022
SMEI: Chinese Public Medical Institution Drug Sales Surged 7.2% in 202...
5/17/2022
NHSA Completes Building of Unified National BMI Information Platform
5/17/2022
433 Listed Chinese Pharma Companies Report Their Annual Performance in...
5/16/2022
Visus and Zhaoke Enter Exclusive Licensing Deal for Brimochol PF and C...
5/16/2022
Kelun Out-licenses Anticancer Drug Candidate to MSD in $1.4B Deal
5/16/2022
Pfizer Leads April Approvals in China with Two JAK Inhibitors (PharmaD...
5/13/2022
Green Valley Aborts Trial of Its Alzheimer's Drug amid Fundraisng and ...
5/13/2022
Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021
5/13/2022
SMEI: Top 20 Pharma Cos by Hospital Drug Sales in 2021
5/12/2022
Henlius and Eurofarma Entered into a License Deal for Three Henlius P...
5/12/2022
Merck KGaA Warns of Volatile 2022 Thanks to War in Ukraine and Fresh C...
5/12/2022
China Resources in Talks to Take Sihuan Pharma Private At $3B Valuatio...
5/11/2022
China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...
Page:
71
/
361
Total number of articles:
10809
:
[First]
[<<]
[69]
[70]
[71]
[72]
[73]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit